This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Alcon (ALC)

Tipranks - Thu May 7, 10:52AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Idexx Laboratories (IDXX) and Alcon (ALC).

Claim 55% Off TipRanks

Idexx Laboratories (IDXX)

Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Idexx Laboratories today and set a price target of $675.00. The company’s shares closed last Wednesday at $573.61.

According to TipRanks.com, Block is a 4-star analyst with an average return of 4.1% and a 47.0% success rate. Block covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Tandem Diabetes Care, and Elanco Animal Health. ;'>

Currently, the analyst consensus on Idexx Laboratories is a Moderate Buy with an average price target of $701.29, implying a 24.8% upside from current levels. In a report released yesterday, TipRanks – OpenAI also upgraded the stock to Buy with a $625.00 price target.

See the top stocks recommended by analysts >>

Alcon (ALC)

William Blair analyst Steven Lichtman maintained a Hold rating on Alcon today. The company’s shares closed last Wednesday at $66.25.

According to TipRanks.com, Lichtman is a 5-star analyst with an average return of 12.6% and a 51.4% success rate. Lichtman covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Sight Sciences, and Cooper Co. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alcon with a $96.73 average price target, implying a 46.4% upside from current levels. In a report issued on April 24, TipRanks – Anthropic also reiterated a Hold rating on the stock with a CHF65.00 price target.

Read More on IDXX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.